FDA Issues SHOCKING Update – COVID Vaccine Risks!

Person holding a vial labeled COVID-19 Vaccine.

In a shocking update, the FDA has expanded warnings on Pfizer and Moderna COVID-19 vaccines due to heart risks like myocarditis and pericarditis.

See the tweet below!

These developments come as new safety information urges increased transparency about post-vaccine heart inflammation, particularly affecting young males.

The FDA has mandated label updates for Pfizer/BioNTech and Moderna vaccines to reflect risks of cardiovascular issues.

New warning labels come as abnormal cardiac MRI findings reveal markers for myocardial injury.

While myocarditis and pericarditis have been known side effects, the FDA aims to adjust the at-risk age range to males 16 through 25 years.

The FDA sent letters on April 17, emphasizing the “new safety information” for COVID-19 mRNA vaccines.

The vaccines have already warned about these heart risks, especially in young males.

However, Pfizer and Moderna now have 30 days to propose changes or contest the updates.

Previously, the highest risk warnings applied to males aged 18 to 24 with Moderna and 12 to 17 for Pfizer.

Now, it encompasses older adolescents and young adults, aiming for clarity and caution.

This update aligns with new Trump administration policies focusing on high-risk groups for COVID-19, including seniors.

“We have launched down this multi-year campaign of booster after booster after booster and distrust of the American public, and we do not have gold standard science to support this for average-risk, low-risk Americans,” said newly appointed Center for Biologics Evaluation and Research director Vinay Prasad, cited by Biospace.

As controversy swirls, the CDC assures that the mRNA COVID-19 vaccines have undergone “the most intensive safety analysis in U.S. history.”

Yet, some figures falsely claim these vaccines pose high danger. With limited vaccine approvals for seniors and high-risk individuals already discussed, this divide highlights challenges in maintaining public trust.

Myocarditis remains a rare side effect, occurring in about 38 males per million in specified age groups. Nevertheless, the FDA’s call for routine COVID-19 vaccines faces scrutiny.

The advisory committee will discuss strain selections, but FDA officials want more evidence before recommending regular vaccinations for healthy children and adults.

The Trump-era policy includes restricting vaccines to individuals 65 years and older, or those with underlying conditions, starting this fall.

Novavax’s COVID-19 vaccine, for instance, has been approved with restrictions. Whether the lasting impact of these changes will instill confidence or sow confusion remains to be seen.